Back HIV/AIDS HIV/AIDS Topics HIV Prevention

Federal Syringe Access Policy: Where Are We Now?

Late last year Congress voted to reinstate a ban on federal funding for syringe exchange programs, which had only been repealed in 2009 after 2 decades of concerted advocacy by harm reduction and HIV and hepatitis prevention activists. Matt Sharp talked with Laura Thomas, the Drug Policy Alliance's Interim State Director for California and a long-time needle exchange volunteer, about the status of syringe access in the U.S. and where do we go from here.alt

Read more:

March 21: National Day of Action on Syringe Access

Last December Congress voted to reinstate a ban on federal funding for syringe exchange programs, overturning a hard-won 2009 victory by harm reduction and HIV and viral hepatitis prevention advocates. Access to clean syringes is a proven approach to reducing transmission of HIV, hepatitis B and C, and other blood-borne diseases, without increasing drug use.alt

Read more:

Coverage of the 2012 Conference on Retroviruses and Opportunistic Infections

HIVandHepatitis.com's complete coverage of the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012), March 5-8, 2012.

Featuring new HIV drugs, HIV cure research, biomedical prevention, HIV-related conditions and complications, basic science, hepatitis C, and HIV/HCV coinfection.

Full listing by topic

HIVandHepatitis.com CROI 2012 section

3/16/12

alt

 

CROI 2012: The Real Life Challenge of HIV Treatment as Prevention [VIDEO]

"Treatment as prevention" was a widely referenced topic at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) this month in Seattle, and has been a dominant theme in HIV/AIDS news for the past couple years. Rick Elion explains why this approach may be difficult to put into practice.alt

Read more:

CROI 2012: HIV Superinfections May Happen as Often as First Infections

Two studies of people with HIV in Rakai, Uganda, and Mombasa, Kenya, presented at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) last week in Seattle show that the rate at which they acquired second, subsequent strains of HIV was about the same as the HIV incidence rate in the general population.

Read more: